Doctor's hand using a digital stethoscope with a heart rate monitor graphic.

GENinCode

Cardiology genetics testing that identifies cardiovascular risk earlier and more accurately than traditional methods.

GENinCode is a predictive genetics company based in Oxford, UK and Irvine, CA, dedicated to the prevention of cardiovascular disease — the leading cause of death globally. Their patented technology combines genetic and clinical data to provide a comprehensive risk assessment.

Engage NSS for GENinCode → contact@northstarsci.com

Visit genincode.com

Product Portfolio

GENinCode's testing portfolio includes:

  • CARDIO inCode-Score® — Comprehensive cardiovascular risk assessment combining genetic and clinical data

  • LIPID inCode® — Familial hypercholesterolemia and dyslipidemia testing

  • THROMBO inCode® — Thrombosis and venous thromboembolism risk assessment

Who GENinCode is for

GENinCode's tests are designed for clinicians who need to identify cardiovascular and thrombotic risk before symptoms appear:

  • Cardiologists managing patients with cardiovascular risk factors or family history of heart disease

  • Lipidologists treating hereditary lipid disorders and statin-resistant cases

  • Primary care physicians screening high-risk patients in preventive care settings

  • Hospitals and integrated delivery networks building genetics-informed preventive cardiology programs

Why North Star Scientific represents GENinCode

NSS is the commercial partner for GENinCode in the United States and Canada. Our team brings 25+ years of cardiology and diagnostics commercial experience from Corning, Thermo Fisher, BD, and Bio-Techne to introducing GENinCode's technology to clinicians who can use it to prevent cardiovascular events in their patients.

What NSS handles for GENinCode:

  • Outbound prospecting to cardiologists, lipidologists, and primary care offices

  • AI-personalized multi-channel outreach across email, LinkedIn, voice, and phone

  • In-person trade show representation at cardiology and primary care conferences

  • Account-level engagement with hospital systems and integrated delivery networks

  • Pipeline management and monthly reporting to the GENinCode commercial team

How to engage

Coverage: United States and Canada NSS team: Pat Téa, Pearl Orbeta Contact: contact@northstarsci.com | 1-888-565-4957

Get in touch about GENinCode

Visit GENinCode

For product specifications, clinical evidence, regulatory status, and ordering information, visit GENinCode directly:

genincode.com/homepage-us/